PubMed

Metabolic consequences of antihypertensive therapy.

Flamenbaum W.

Ann Intern Med. 1983 May;98(5 Pt 2):875-80.PMID: 6847029 [PubMed - indexed for MEDLINE]Related articles

Metabolic consequences of treating hypertension.

Pool PE, Seagren SC, Salel AF.

Am J Hypertens. 1991 Jul;4(7 Pt 2):494S-502S. Review.PMID: 1680346 [PubMed - indexed for MEDLINE]Related articles

Metabolic considerations in the approach to diabetic hypertensive patients.

Zawada ET Jr.

Am J Med. 1989 Dec 8;87(6A):34S-38S. Review.PMID: 2688412 [PubMed - indexed for MEDLINE]Related articles

The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.

Middeke M, Richter WO, Schwandt P, Holzgreve H.

Int J Clin Pharmacol Ther. 1997 Jun;35(6):231-4.PMID: 9208337 [PubMed - indexed for MEDLINE]Related articles

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.

J Hypertens. 2003 Aug;21(8):1563-74.PMID: 12872052 [PubMed - indexed for MEDLINE]Related articles

Metabolic changes with antihypertensive therapy of the salt-sensitive patient.

Holland OB, Pool PE.

Am J Cardiol. 1988 Jun 15;61(16):53H-59H. Review.PMID: 3289352 [PubMed - indexed for MEDLINE]Related articles

Role of metabolic risk factors in cardiovascular prognosis of systemic hypertension.

Louis WJ, Howes LG, Straznicki N, Krum H, Phillips P, Broadbear J, McNeil JJ.

Am J Cardiol. 1990 May 2;65(17):43H-45H. Review.PMID: 2184652 [PubMed - indexed for MEDLINE]Related articles

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Scheen AJ.

Drugs. 2004;64(22):2537-65. Review.PMID: 15516153 [PubMed - indexed for MEDLINE]Related articles

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study.

Grassi G, Seravalle G, Dell'Oro R, Trevano FQ, Bombelli M, Scopelliti F, Facchini A, Mancia G; CROSS Study.

J Hypertens. 2003 Sep;21(9):1761-9.PMID: 12923410 [PubMed - indexed for MEDLINE]Related articles

Effects of antihypertensive therapy on glucose and lipid metabolism.

Zehetgruber M, Christ G, Mundigler G, Gabriel H, Huber K.

Wien Klin Wochenschr. 1996 Dec 27;108(24):775-80. Review.PMID: 9017889 [PubMed - indexed for MEDLINE]Related articles

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.

Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J.

Arch Intern Med. 1998 Apr 13;158(7):741-51.PMID: 9554680 [PubMed - indexed for MEDLINE]Related articlesFree article

[Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study]

Goicolea I, Fernández González R, Piniés J, Garrido J, Martínez JM, Armenteros S, Moreno Carretero E.

Nefrologia. 2002;22(2):170-8. Spanish. PMID: 12085418 [PubMed - indexed for MEDLINE]Related articles

Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy.

Krum H, Skiba M, Gilbert RE.

Diabet Med. 2003 Sep;20(9):708-12.PMID: 12925048 [PubMed - indexed for MEDLINE]Related articles

Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems.

Ernsberger P, Koletsky RJ.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Jul;373(4):245-58. Epub 2006 Jun 17. Review.PMID: 16783586 [PubMed - indexed for MEDLINE]Related articles

[Retrospective studies and prospects of therapy for hypertension]

Maisch B, Brilla C, Kruse T, Noll B, Bethge C.

Herz. 1995 Dec;20(6):370-89. Review. German. PMID: 8582697 [PubMed - indexed for MEDLINE]Related articles

[Possibilities of using indices of vascular wall function as markers of negative metabolic effects of treatment with thiazide diuretics in patients with essential hypertension]

Semenkin AA.

Ter Arkh. 2007;79(4):31-8. Russian. PMID: 17564015 [PubMed - indexed for MEDLINE]Related articles

Aliskiren: an oral renin inhibitor for the treatment of hypertension.

Lam S, Choy M.

Cardiol Rev. 2007 Nov-Dec;15(6):316-23. Review.PMID: 18090068 [PubMed - indexed for MEDLINE]Related articles

[The effects of angiotensin II receptor antagonists on glucose, lipid, and uric acid metabolism in essential hypertensives]

Takizawa H, Shimamoto K.

Nippon Rinsho. 1999 May;57(5):1137-40. Review. Japanese. PMID: 10361447 [PubMed - indexed for MEDLINE]Related articles

Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.

Kintscher U, Bramlage P, Paar WD, Thoenes M, Unger T.

Cardiovasc Diabetol. 2007 Apr 3;6:12.PMID: 17407587 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term safety of antihypertensive therapy.

Grossman E, Messerli FH.

Prog Cardiovasc Dis. 2006 Jul-Aug;49(1):16-25. Review.PMID: 16867847 [PubMed - indexed for MEDLINE]Related articles